ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

EQRXW EQRx Inc

0.0455
0.00 (0.00%)
Jun 06 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.0418
Ask Price 0.0494
News -
Share Name Share Symbol Market Stock Type
EQRx Inc EQRXW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0455 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.0455 0.0455
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0  0.0455 USD

EQRx Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 22.19M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News EQRx

Real-Time news about EQRx Inc (NASDAQ): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EQRXW Message Board. Create One! See More Posts on EQRXW Message Board See More Message Board Posts

EQRXW Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have shown assuring Phase 3 data (aumolertinib and sugemalimab), and multiple other clinical-stage programs.